# Los Angeles Biosciences, Inc. — Form D

Los Angeles Biosciences, Inc. of PLAYA DEL REY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-24. The offering totals $5.0M, of which $4.9M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2025-06-24
- Form: D
- Accession: 0002074477-25-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $4.9M
- Remaining: $131K
- Investors: 17
- Date of first sale: 2025-06-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-549732

## Issuer

- Name: Los Angeles Biosciences, Inc.
- CIK: 0002074477
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 419 WATERVIEW STREET, PLAYA DEL REY, CA, 90293
- Phone: 907.350.7848

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Derya L Kelter | Director | Playa Del Rey, CA |
| Ketan L Patel | Director | Calabasas, CA |
| Derya L Kelter | Executive Officer | Playa Del Rey, CA |
| Jeff L Nichols | Executive Officer | Atlanta, GA |

## More

- [CIK 2074477 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2074477&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002074477-25-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.